The number of AT2R binding sites, revealed by radiolabeled ang-II binding, are elevated in the temporal cortex in AD (28); however, AGTR2 gene expression has also been reported to be lower in AD (14). The gene discussed is AGTR2; the disease is Alzheimer disease.